A putative placebo comparison of the SCOOP and LIFE trials

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 5, Issue 2, 2004, Pages 59-63

  Meredith, Peter A ^a   Murray, Lilian S ^a   Murray, John J V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Candesartan; Imputed placebo; LIFE; Losartan; SCOPE

Indexed keywords

AMILORIDE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; LOSARTAN; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL STUDY; CLINICAL TRIAL; DRUG EFFICACY; EXPERIMENTAL DESIGN; FATALITY; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; OUTCOMES RESEARCH; STATISTICAL SIGNIFICANCE; STROKE;

EID: 3542996278     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2004.011     Document Type: Article

References (16)

1. Collins R, Peto R, MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
2. Staessen JA, Wang J-G, Thijs L. Cardiovascular prevention and blood pressure reduction:A quantitative overview updated until 1 March 2003. J Hypertens 2003;21:1055-76.
3. Furberg CD, Wright Jr JT, Davis BR et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
4. Dahlof B, Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):A randomised trial against atenolol. Lancet 2002;359:995-1003.
5. Lithell H, Hansson L, Skoog I et al. The study on cognition and prognosis in the elderly (SCOPE): Principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21:875-86.
6. Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? JAMA 1998;279:1903-07.
7. Peart S, Brennan PJ, Broughton P et al. Medical Research Council trial of treatment of hypertension in older adults: Principal results. BMJ 1992;304:405-12.
8. Hasselblad V, Kong DF. Statistical methods for comparison to placebo in active-control trials. Drug Info J 2001;35:435-49.
9. MacMahon S, Rodger A. The effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1994. J Cardiovasc Med Biol 1993;279:1903-07.
10. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Brit Med Bull 1994;50:272-98.
11. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362: 1527-35.
12. Psaty B, Lumley T, Furberg CD et al. Health outcomes associated with various antihypertensive therapies used as first line agents: A network meta-analysis. JAMA 2003;289:2534-44.
13. Hansson L, Zanchetti I, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62.
14. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
15. Messerli FH, Beevers DG, Franklin SS, Pickering TG. Beta-blockers in hypertension - The emperor has no clothes: An open letter to present and prospective drafters of new guidelines for the treatment of hypertension. Am J Hypertens 2003;16:870-3.
16. Messerli FH. The LIFE study:The straw that should break the camel's back. Eur Heart J 2003;24:487-9.